Check out your Company Bowl for anonymous work chats.
Paige, a global leader in AI-based digital diagnostics, today announced a Series C funding round of $100 million to accelerate the Company’s efforts to transform digital pathology by unlocking insights from each patient’s sample so pathologists, care teams and researchers can make decisions more confidently and efficiently to optimize outcomes. The Series C financing was led by Casdin Capital and Johnson & Johnson Innovation – JJDC, Inc. (JJDC), the strategic venture capital arm of Johnson & Johnson. Existing investors and other funds are also participating in the round.
Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology
We are proud to share that we've achieved CE Marks for our breast cancer detection and prostate cancer grading and quantification AI-based digital diagnostics. We remain committed to advancing new products that unlock insights from patient samples and improve pathology workflow as well as diagnostic confidence in cancer.
Paige Achieves CE Marks for Breast Cancer Detection and Prostate Cancer Grading and Quantification AI-based Digital Diagnostics
Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer
Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer
Paige Receives FDA Clearance for the FullFocus™ Viewer for Digital Pathology
Paige Receives FDA Clearance for the FullFocus™ Viewer for Digital Pathology
Company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment.
Paige Secures Additional $15M from Goldman Sachs, for a Total Series B Funding Round of $70M
Paige secures an additional $5M in funding from Goldman Sachs
Paige adds $5M from Goldman Sachs to double down on AI-based cancer therapies
Invicro and Paige Partner to Offer Comprehensive Tissue Biomarker Profiling Services
Invicro and Paige Partner to Offer Comprehensive Tissue Biomarker Profiling Services
Paige Welcomes Marty Chavez to our board of directors
R. Martin Chavez Joins Paige's Board of Directors
Paige Raises $45 Million to Accelerate the Future of Pathology
Paige Raises $45 Million to Accelerate the Future of Pathology
Philips and Paige team up to bring Artificial Intelligence (AI) to clinical pathology diagnostics
Philips and Paige team up to bring Artificial Intelligence (AI) to clinical pathology diagnostics